GLP-1 action in the mouse bed nucleus of the stria terminalis by Williams, DL et al.
lable at ScienceDirect
Neuropharmacology 131 (2018) 83e95Contents lists avaiNeuropharmacology
journal homepage: www.elsevier .com/locate/neuropharmGLP-1 action in the mouse bed nucleus of the stria terminalis
Diana L. Williams a, Nicole A. Lilly a, Ian J. Edwards b, Pallas Yao b, 1, James E. Richards b,
Stefan Trapp b, *
a Psychology Department & Program in Neuroscience, Florida State University, USA
b Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology & Pharmacology, University College London, London,
WC1E 6BT, UKa r t i c l e i n f o
Article history:
Received 6 June 2017
Received in revised form
13 October 2017
Accepted 3 December 2017









StressAbbreviations: 3V, third ventricle; AAV, adeno-ass
cerebrospinal ﬂuid; Arc, arcuate nucleus; BNST, bed n
CeA, central amygdaloid nucleus; DMH, dorsomedial
(9-39); GLP-1, glucagon-like peptide-1; GLP-1R, GLP-1
LS, lateral septum; LV, lateral ventricle; ME, med
amygdaloid nucleus; MM, medial mammillary nucle
nucleus; opt, optic tract; MPA, medial preoptic are
nucleus accumbens; NTS, nucleus of the solitary trac
paraformaldehyde; Pir, piriform cortex; PPG, preprogl
nucleus; SHi, septohippocampal nucleus; TTX, tetro
nucleus of the hypothalamus; VP, ventral pallidum; V
* Corresponding author.
E-mail address: s.trapp@ucl.ac.uk (S. Trapp).
1 Present Address: Department of Genetics and Com
Chan School of Public Health, Boston, Massachusetts
https://doi.org/10.1016/j.neuropharm.2017.12.007
0028-3908/© 2017 The Author(s). Published by Elseva b s t r a c t
Glucagon-like peptide-1 (GLP-1) injected into the brain reduces food intake. Similarly, activation of
preproglucagon (PPG) cells in the hindbrain which synthesize GLP-1, reduces food intake. However, it is
far from clear whether this happens because of satiety, nausea, reduced reward, or even stress. Here we
explore the role of the bed nucleus of the stria terminalis (BNST), an area involved in feeding control as
well as stress responses, in GLP-1 responses.
Using cre-expressing mice we visualized projections of NTS PPG neurons and GLP-1R-expressing BNST
cells with AAV-driven Channelrhodopsin-YFP expression. The BNST displayed many varicose YFPþ PPG
axons in the ventral and less in the dorsal regions. Mice which express RFP in GLP-1R neurons had
RFPþ cells throughout the BNST with the highest density in the dorsal part, suggesting that PPG neuron-
derived GLP-1 acts in the BNST. Indeed, injection of GLP-1 into the BNST reduced chow intake during the
dark phase, whereas injection of the GLP-1 receptor antagonist Ex9 increased feeding. BNST-speciﬁc GLP-
1-induced food suppression was less effective in mice on high fat (HF, 60%) diet, and Ex9 had no effect.
Restraint stress-induced hypophagia was attenuated by BNST Ex9 treatment, further supporting a role for
endogenous brain GLP-1. Finally, whole-cell patch clamp recordings of RFPþ BNST neurons demonstrated
that GLP-1 elicited either a depolarizing or hyperpolarizing reversible response that was of opposite
polarity to that under dopamine.
Our data support a physiological role for BNST GLP-1R in feeding, and suggest complex cellular re-
sponses to GLP-1 in this nucleus.
© 2017 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
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ier Ltd. This is an open access artic(PPG) neurons of the nucleus of the solitary tract (NTS) are widely
considered to play an important role in the control of food intake,
body weight, and responses to stress (Gaykema et al., 2017; Holt
and Trapp, 2016; Maniscalco et al., 2015; Trapp and Cork, 2015).
These neurons project throughout the brain to many regions in
which GLP-1 receptors (GLP-1R) are expressed (Cork et al., 2015;
Llewellyn-Smith et al., 2011). A variety of behavioral effects of
GLP-1R activation can be elicited by selectively targeting some of
these locations (Alhadeff et al., 2012, 2014; Dossat et al., 2013;
Richard et al., 2014; Shirazi et al., 2013; Williams, 2014).
Most investigations of the behavioral effects of brain GLP-1R
manipulations have been performed in rat, and data from studies
in mouse suggest species differences which in some cases have
called into question whether neuronal GLP-1R contributes to the
physiological control of feeding (Sisley et al., 2014). However, hy-
pothalamic knockdown of GLP-1R in the mouse increases food
intake (Burmeister et al., 2017), although the speciﬁc cellle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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was not recapitulated by knockdown of GLP-1R in SIM1-expressing
neurons of the paraventricular nucleus (PVN) or POMC neurons of
the arcuate nucleus (ARC), however, the loss of GLP-1Rs in PVN
neurons does attenuate a variety of physiological and behavioral
responses to both acute and chronic stress (Ghosal et al., 2017).
A number of recent studies targeting mesolimbic nuclei in rat
have demonstrated a role for GLP-1R in food intake. In rats, acti-
vation of GLP-1R in major centers of the mesolimbic dopamine
pathway involved in reward (nucleus accumbens (NAc) and ventral
tegmental area (VTA)), reduces eating motivation, food intake, and
(in the NAc) palatability (Alhadeff et al., 2012; Dossat et al., 2011,
2013). These studies suggest a role for GLP-1 in hedonic feeding,
but the details of GLP-1 innervation and GLP-1R expression in
mesolimbic areas is poorly understood. The availability of mouse
strains expressing Cre recombinase under the PPG or the GLP-1R
promoters enables further investigation (Parker et al., 2012;
Richards et al., 2014).
Here we present analysis of projections from NTS PPG neurons
to the mesolimbic system as well as identifying bed nucleus of the
stria terminalis (BNST) GLP-1R-derived projections using Cre-
dependent virally assisted neuroanatomical tracing. We demon-
strate that the BNST, an area known to be involved in feeding and
stress responses, receives substantial innervation from NTS PPG
neurons, and that GLP-1R expressing neurons of the BNST project
widely to other brain areas. We then establish food intake sup-
pressive effects when BNST GLP-1Rs are stimulated both exoge-
nously and endogenously. Finally, we show that individual GLP-1R-
expressing neurons in the BNST respond to GLP-1 stimulation with
either excitation or inhibition of electrical activity.
2. Material and methods
2.1. Animals
Naïvemale C57Bl6J mice (Jackson Laboratories) were used in the
behavioral experiments. Studies examining distribution of GLP-1
neuronal axons utilized mGLU-124 Venus expressing mice
(Reimann et al., 2008) (referred to as YFP-PPG) andmGlu-Cre:tdRFP
mice (Parker et al., 2012). Mice that express Cre-recombinase under
the control of the Glp1r promoter were crossed with the ROSA26-
tdRFP reporter strain to yield GLP-1R-Cre:tdRFP progeny (Cork
et al., 2015; Richards et al., 2014). Animals were maintained on a
12:12 light:dark schedule in a temperature controlled vivarium
with ad lib access to water and standard chow unless otherwise
speciﬁed below. All experiments performed in the UK were carried
out in accordance with the UK Animals (Scientiﬁc Procedures) Act,
1986, with appropriate ethical approval. Studies performed in the
US were approved by the Florida State University Institutional
Animal Care and Use Committee and conformed to the standard of
the National Research Council Guide for the Care and Use of Lab-
oratory Animals, 2011.
2.2. Anatomical analysis
2.2.1. Fourth generation neuroanatomical tracing
Selective ﬂuorescent protein expression by cre-dependent
adeno-associated virus (AAV) injection, also termed ‘fourth gener-
ation neuroanatomical tracing’ (Wouterlood et al., 2014) was
employed to verify that PPG axons identiﬁed in the BNST originate
from NTS PPG neurons and to identify projection targets of BNST
neurons expressing GLP1-R. AAV particles were produced as
described by Murray et al. (2011). Brieﬂy, pAAV-EF1a-double
ﬂoxed-hChR2(H134R)-EYFP-WPRE-HGHpA (gift from Karl Dei-
sseroth; Addgene plasmid # 20298), AAV1 (pH21), AAV2 (pRV1)helper plasmids and the adenovirus helper plasmid pFD6 were co-
transfected in HEK293 cells to produce AAV virions containing a 1:1
ratio of type 1 and 2 capsid proteins. 64 h post-transfection, cells
were harvested and AAVs were puriﬁed from lysates using 1 ml
HiTrap heparin columns (Sigma). Eluted virions were concentrated
using Amicon Ultra-4 centrifugal ﬁlter devices (Millipore
UFC810024).
Adult GLP-1R-CRE:tdRFP (female; n ¼ 3) and mGlu-Cre:tdRFP
(male; n ¼ 3) mice were anaesthetised by intramuscular injection
of ketamine (75 mg/kg) and medetomidine (0.5 mg/kg) to induce
deep anaesthesia which was conﬁrmed by the absence of a pedal
withdrawal reﬂex. The mGlu-Cre:tdRFP mice were placed in a
stereotaxic frame with their head tilted downwards to expose the
neck. An incision was made along the midline and neck muscles
were parted to expose the dura mater, which was ruptured, to
facilitate bilateral injection into the NTS with 200 nl of AAV
encoding ChR2:EYFP infused at 50 nl per min. The injection co-
ordinates were (from calamus scriptorius): 0.1 mm rostral, 0.5 mm
lateral, 0.35 mm ventral to surface. Anaesthesia was reversed using
Antisedan (5 mg/kg) and buprenorphine analgesia (0.05 mg/kg per
day; s.c. for 48 h) and s.c saline solution (150 ml per 30 g body-
weight) were provided.
GLP-1R-Cre:tdRFP mice, ﬁxed in a stereotaxic frame, had cranial
windows drilled to allow injections with 150 nl (50 nl/min) of AAV
encoding ChR2:EYFP in each BNST location in both hemispheres to
target GLP-1R neurons. The coordinates used to target the BNST
were 0.25 mm rostral, 0.8 mm lateral, 4.25 and 4.75 mm ventral to
the surface of the skull from Bregma. This ensured virus reached
the BNST both dorsal and ventral of the anterior commissure.
Anaesthesia was reversed and analgesia provided as described
above. 21 days later, animals were transcardially perfuse-ﬁxed as
described below. Successful targeting was conﬁrmed by the
observation of somatic expression of ChR2 in tdRFP-positive cell
bodies in the target area.
2.2.2. Immunoﬂuorescence
Mice, either naïve or three weeks after stereotaxic injection of
AAV, were anaesthetised as described above, heparinized (50 units
bolus) and transcardially perfused with 50 ml 0.1 M phosphate
buffer (PB) followed by 50ml of ﬁxative (4% PFA in 0.1 M PB). Brains
were extracted and postﬁxed overnight at 4 C in ﬁxative, then
cryoprotected with 30% w/v sucrose in 0.1 M PB. Brains were
sectioned coronally at 30 mm thickness on a cryostat (OTF cryostat;
Bright Instruments Ltd.; Luton; UK).
Sections were blocked with 0.1% Triton X-100 and 10% normal
goat serum diluted in 0.1 M PB for 1 h at room temperature, and
were then incubated overnight at 4 C with chicken anti-GFP
(Catalogue #AB13970, lot #623923; Abcam, Cambridge MA, USA;
YFP-PPG brains) or rabbit anti-DsRED (Clontec #632496; GLP-1R-
Cre-tdRFP brains) (both 1:1000) in blocking solution. Subse-
quently, sections werewashed 3 times for 5min in 0.1M PB at room
temperature, followed by incubation with a ﬂuorescently labeled
secondary antibody, either goat anti-chicken IgG Alexa Fluor 488
(Catalogue# A-11039, Invitrogen) or sheep anti-rabbit IgG CY-3
(Catalogue# C2306, Sigma Aldrich, St Louis MO, USA) (both
1:500), in blocking solution for 2 h. Sections were washed again 3
times for 5 min in 0.1 M PB at room temperature and placed onto
polysine-coated slides. Vectashield mounting medium (Vector
Labs) was dispersed over the air dried sections and overlayedwith a
coverslip. Antibody speciﬁcity was conﬁrmed by lack of positive
staining in sections from naïve tissue. These primary antibodies
have been well characterized in previous studies in our laboratory,
demonstrating that the anti-GFP antibody recognizes EYFP and the
anti-DsRED antibody recognizes tdRFP (Cork et al., 2015; Llewellyn-
Smith et al., 2011). Fluorescent cells were visualized using a Leica
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Milton Keynes, UK) and images captured with a RetigaTM 3000
CCD camera (QImaging, Surrey, Canada). Images were merged us-
ing ImageJ software and composited using Microsoft ICE software.2.3. Feeding experiments
Male C57BL6 mice weighing an average of 22 g at the time of
surgery were individually housed for these experiments. Under
isoﬂurane anaesthesia, most mice were stereotaxically implanted
with unilateral guide cannulas (26 G, Plastics One, Roanoke, VA,
USA) at 0.5 mm anterior to Bregma, 0.7 mm lateral to midline, and
1.75 mm ventral to skull surface. Injectors (33 G) extended below
the end of the guide by 3.25 mm to target the BNST. One group
received unilateral guide cannulas to allow targeting of the NAc,
implanted at 1.0 mm anterior to Bregma, 1.0 mm lateral to midline,
and 2.0 mm ventral to skull surface, for use with injectors
extending 2.75 mm below the end of the guide cannula. Cannula
placements were veriﬁed histologically after behavioral experi-
ments were completed, and n numbers noted here represent only
mice with correct placements (hit rate ¼ 85%). Recovered mice
were habituated to handling and the injection procedure for at least
1 week before experiments. Food intake during the 20-h period
post habituation saline injection did not differ from intake
measured on non-injection days.2.3.1. Dose responses
This series of experiments utilized within-subjects designs, such
that mice in a given dose response study received each injection
condition in counterbalanced order separated by 72e96 h. On
experiment days, chow was removed 3 h before dark onset and
mice (n ¼ 15, mean ± SEM body weight 25.9 ± 0.1 g at start of the
experiment) were injected with 0.5 ml saline or either 0.1, 0.3, or
1.0 mg of GLP-1 (American Peptide, Vista, CA, USA) approximately
30 min before dark onset. Another group of mice (n ¼ 16,
mean ± SEM body weight 24.7 ± 0.1 g at start of the experiment)
received intra-BNST injections of saline, 3 or 10 mg of the GLP-1R
antagonist exendin (9-39) (Ex9), (American Peptide, Vista, CA,
USA). These doses of GLP-1 and Ex9 were previously determined to
be subthreshold for effect when delivered to the lateral ventricle of
mice (unpublished preliminary data). Food was returned immedi-
ately before dark onset, and consumption was measured at 1, 2, 4,
and 22 h. Additional groups of mice were maintained on a diet
containing 60% fat (HFD; D12492, Research Diets, New Brunswick,
NJ, USA) instead of chow for 2 weeks prior to injections. These
groups received the same treatment as described above, either,
saline and GLP-1 (n ¼ 11, mean ± SEM body weight 28.8 ± 0.3 g at
start of the experiment), or saline and Ex9 (n¼ 9, mean ± SEM body
weight 29.4 ± 0.3 g at start of the experiment). In all experiments,
body weight was recorded daily, but because there were no effects
from drug treatment on weight in any study, these data are not
shown.
Because the NAc, in close proximity to the BNST, has been
implicated in feeding effects of GLP-1 in the rat (Alhadeff et al.,
2012; Dossat et al., 2011), we examined the effect of the same
doses of Ex9 delivered to the NAc, using the within-subjects design
as described above. Naïve chow-maintained mice (n ¼ 12,
mean ± SEM body weight 23.5 ± 0.1 g at start of the experiment)
were habituated to the injection procedures as described above,
then they were injected with saline, 3 or 10 mg of Ex9 approxi-
mately 30 min before dark onset. Food was returned immediately
before dark onset, and intake was measured 1, 2 and 22 h later.
Drug treatments occurred in counterbalanced order separated by
48e72 h, with all mice receiving all conditions.2.3.2. Stress-induced hypophagia
Mice maintained on chow diet received either intra-BNST saline
(n ¼ 5, mean ± SEM body weight 27.8 ± 0.4 g at the start of the
experiment) or intra-BNST Ex9 (3 mg dose, n¼ 5, mean ± SEM body
weight 26.9 ± 0.2 g at the start of the experiment). On experiment
days, food was removed 4 h before dark onset, and mice were
injected with saline or Ex9 at 45 min before dark. On no-stress
control days, mice were then handled brieﬂy and placed back
into their home cage. On stress days, micewere placed into a plastic
DecapiCone (Braintree Scientiﬁc, Braintree, MA, USA) and
restrained for 30 min. At the end of the 30 min restraint stress
period, they were returned to their home cages. Pre-weighed food
was returned immediately before dark onset, and intake was
measured 1, 2, 4, and 22 h later. Each mouse received both a no-
stress control and stress treatment, so this experiment had a
mixed between/within-subjects design. Body weight was recorded
daily, but as no effect from any treatment was observed, these data
are not shown.
2.4. Electrophysiological recordings
All electrophysiological recordings were performed on adult
transgenic GLP-1R-Cre:tdRFP mice of either sex. Altogether, re-
cordings were obtained from 10 male and 12 female mice. Animals
were culled by isoﬂurane overdose and the forebrain rapidly
excised and transferred into ice-cold low Naþ/low Ca2þ artiﬁcial
cerebrospinal ﬂuid (ACSF) of the following composition (in mmol/
l): 200 sucrose, 2.5 KCl, 28 NaHCO3, 1.25 NaH2PO4, 3 pyruvate 7
MgCl2, 0.5 CaCl2, 7 glucose (pH 7.4). Coronal (200 mm) brain slices
containing the bed nucleus of the stria terminalis (BNST) were
sectioned on a vibratome (Campden Instruments) and kept at 34 C
in ACSF of the following composition (in mmol/l): 118 NaCl, 3 KCl,
25 NaHCO3, 1 MgCl2, 2 CaCl2, 10 glucose (pH 7.4). Experimental
solutions were constantly bubbled with 95% O2/5% CO2.
Recombinant human GLP-1 (7-37) was obtained from Peprotech
(London, UK), Tetrodotoxin (TTX) from Cayman Chemicals, 6,7-
Dinitroquinoxaline-2,3-dione (DNQX) and (2R)-amino-5-
phosphonovaleric acid (APV) from Tocris Bioscience (Bristol, UK),
and dopamine from Sigma. DNQX was prepared as a stock solution
in DMSO. All other stock solutions were prepared in H2O, and
diluted at least 1000 when added to the ACSF.
All patch-clamp recordings were carried out in ACSF at 28e32 C
using an EPC-9 ampliﬁer and Pulse/Pulseﬁt software (HEKA-Elec-
tronics, Germany), as described previously (Cork et al., 2015).
Recording electrodes (3e8 MOhm) were ﬁlled with ‘low Cl’
pipette solution composed of (in mM): 120 K-gluconate, 5 HEPES, 5
BAPTA, 1 NaOH, 1 MgCl2, 1 CaCl2 and 2 K2ATP; pH 7.2. The junction
potential of 10 mV was corrected for ofﬂine. All ﬁgures display
corrected potentials. Both whole-cell and loose-patch recordings
were performedwith the same solution. Holding potentials were as
indicated in the results. Individual BNST cells expressing GLP-1
receptors were identiﬁed by their tdRFP ﬂuorescence. Action po-
tential frequency in individual recordings was determined as
instantaneous frequency obtained with the Strathclyde Electro-
physiology Software package (WinEDR/WinWCP; J. Dempster,
University of Strathclyde, Glasgow, UK). Data are given as
mean ± one S.E.M.
2.5. Statistical analysis
Effects of GLP-1 and Ex9 on food intake were evaluated via one-
way within-subjects ANOVA, with Holm-Bonferroni post-hoc
pairwise comparisons. The effects of restraint stress and intra-BNST
Ex9 on feeding were assessed by mixed-design two-way ANOVA,
with Holm-Bonferroni post-hoc pairwise comparisons. For analysis
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a cell responded to a drug. An unpaired t-test was used to compare
the instantaneous ﬁring rate over 2 min in either the presence or
absence of the drug. A value of p < 0.05 was taken as a positive
response. Effects of drugs on mean membrane potential and mean
ﬁring ratewere then evaluated in cells that had been determined as
responsive, using a paired T-test, unless stated otherwise. P
values < 0.05 (*) and <0.01 (**) were taken to indicate that the data
were signiﬁcantly different.
3. Results
3.1. Anatomy of the central GLP-1 system in the mesolimbic system
3.1.1. Distribution of PPG axons
Analysis of three YFP-PPG brains revealed intense YFP-
immunoreactivity throughout the cytoplasm of PPG neurons,
allowing clear distinction of axons, cell bodies and dendrites
throughout the brain. Densest innervation with PPG axons was
identiﬁed in the hypothalamic nuclei of PVN, dorsomedial hypo-
thalamus (DMH), ARC and periventricular nucleus (Pe) as previ-
ously reported (Llewellyn-Smith et al., 2011).
Substantial numbers of PPG axons were identiﬁed in meso-
limbic areas of the forebrain that were not analyzed in detail pre-
viously. Within these areas, the highest density of PPG axons was
seen in the BNST (Fig. 1A), at approximately 0.14 mm anterior from
Bregma at the anterior commissure. The medial division received
PPG innervation of almost comparable density to the hypothalamic
nuclei, and many PPG axons were found throughout the BNST. The
lateral division of BNST received moderate to high innervation,
which extended into the ventral pallidum (VP) (Fig. 1A).
Rostral to this, PPG axons at low to moderate density were
identiﬁed in the dorsal and ventral parts of the lateral septum (LS)
proximal to the lateral ventricles, the medial septum (MS) and
occasionally the septohippocampal nucleus (SHi) (Fig. 1B and C).
Rarely were PPG axons seen in the rostral portion of the nucleus
accumbens (NAC; Fig. 1F); it was devoid of PPG axons in both the
core (NAcC) and shell (NAcS). More caudally, a moderate density of
PPG axons was observed along the midline in the diagonal band of
Broca (DB) with some PPG axon terminals seen to cross the border
into the NAcS and very occasionally into the NAcC (Fig. 1C). A few
axons were identiﬁed in the cingulate cortex and claustrum (not
shown). The central nucleus (CeM), medial nucleus (MeA) and
extended amygdala (EA) revealed a low to moderate density of PPG
axon innervation (Fig. 1D) and the VTA displayed a moderate
density of PPG axons (Fig. 1E).
3.1.2. NTS-PPG neuron projections to the BNST
NTS PPG neurons from mGlu-Cre:tdRFP mice transduced by
AAVs to express ChR2:eYFP showed strong GFP immunoreactivity
(GFP-IR) in the plasma membrane of the cell bodies, dendrites and
axons, which identiﬁed axons and terminals throughout the brain
originating from the NTS PPG neurons. Analysis of hypothalamic
projections of PPG-Cre neurons revealed a GFP-IR expression
pattern indistinguishable from that seen with the YFP-PPG mice
(compare Fig. 2B and C with Llewellyn-Smith et al. (2011)). This
demonstrates that a signiﬁcant proportion of the YFP axons in these
regions originate from the NTS. For the current study we analyzed
particularly GFP-IR over the rostrocaudal extent covering the BNST
(Fig. 2). In concordance with the observed PPG axon distribution in
the hypothalamus, there is also a strong similarity of NTS-PPG
neuronal projections to BNST and surrounding areas with the
YFP-PPG projections examined in Fig. 1. Whilst it is not possible for
us to assign a percentage value when comparing the two sets of
data (Figs. 1 and 2), it is clear that the presence of NTS-PPGprojections is substantial in the BNST.
3.2. Feeding experiments
3.2.1. Dose responses
Intra-BNST GLP-1 injection signiﬁcantly suppressed chow intake
at 1, 2, and 4 h after dark-onset (F's (3, 14) ¼ 34.47, 35.73, 55.70,
respectively, P's < 0.0001) (see Fig. 3A). At 1 h, all doses of GLP-1
(0.1, 0.3, and 1.0 mg) differed from vehicle (P's < 0.01), and at 2
and 4 h, the magnitude of effect was dose-related with all treat-
ment conditions differing signiﬁcantly from one another
(P's < 0.05). There were no effects on overnight intake (Fig. 3A). In
chow-maintained mice, BNST GLP-1R antagonist treatment tended
to increase feeding at 1 h after dark onset, but this did not reach
signiﬁcance (F (2, 15) ¼ 3.309, P ¼ 0.055). Ex9 did signiﬁcantly
increase feeding in these subjects at 2 and 4 h after dark onset (F's
(2, 15) ¼ 7.84, 5.64, respectively, P's < 0.01), with both the 3 and
10 mg doses differing from vehicle (P's < 0.01) (Fig. 3B), with no
effect on overnight intake (Fig. 3B). In separate groups of mice
maintained on HFD instead of chow, intra-BNST GLP-1 signiﬁcantly
suppressed feeding at 1 and 2 h post-dark onset (F's (3, 10) ¼ 7.55,
4.88, respectively, P's < 0.05), but not all doses were effective, and
there were no effects at 4 h or overnight (Fig. 3C). At 1 h, only the
0.3 and 1.0 mg doses of GLP-1 suppressed intake relative to vehicle
(P's < 0.05) and at 2 h, only the 1.0 mg dose was effective (P < 0.05).
Intra-BNST Ex9 failed to affect intake at any time in mice main-
tained on HFD (Fig. 3D).
When Ex9 was delivered to the NAc, instead of the BNST, in
chow-maintained mice, no signiﬁcant effects on food intake were
observed (Fig. 4).
3.2.2. Stress-induced hypophagia
The 30-min restraint stress tended to suppress intakes at all
time-points measured, but a main effect of stress was observed
only for overnight intake (F (1, 8) ¼ 5.38, P < 0.05), and there were
no pairwise signiﬁcant differences. At 4 h after dark onset, there
was a signiﬁcant interaction between stress and Ex9 (F (1, 8)¼ 9.42,
P < 0.05), where stress potently suppressed chow intake in the
BNST vehicle group (P < 0.01) only, with no effect of stress in the
Ex9 group (see Fig. 5). Intake in the Ex9 group after stress was
signiﬁcantly higher than that of the vehicle group (P < 0.05).
3.3. BNST electrophysiology
GLP-1R expressing BNST neurons were identiﬁed by their red
ﬂuorescence, and recordings were performed on cells both dorsal
and ventral from the anterior commissure under optical control. No
differencewas observed in the response to GLP-1 or dopamine or in
the basic electrical properties of GLP-1R neurons from these two
locations. Similarly no differences were observed based on the sex
of the animals used.
In an initial set of experiments 100 nM GLP-1 was applied to the
bath in a cell-attached loose patch conﬁguration. GLP-1R neurons
had a resting ﬁring frequency of 3.3± 1.0 Hz, which either increased
to 5.6 ± 1.6 Hz (n ¼ 6, p < 0.01, paired t-test) or decreased to
2.1 ± 1.0 Hz (n ¼ 8, p < 0.05, paired t-test) under GLP-1 (Fig. 6A and
B). This was surprising, given that GLP-1R is considered to couple to
Gs proteins, and thus excitatory responses only might have been
expected. Consequently, a more detailed analysis of the electrical
properties of these cells was performed.
Three different electrophysiological types of BNST neurons have
been described previously in both rat and mouse (Daniel et al.,
2017; Hammack et al., 2007) with type III the most abundant
BNST neuron population in mouse and type II in rat (Daniel et al.,
2017). Type II were characterized by rebound spiking or burst-
Fig. 1. Projections from YFP-PPG neurons in the brainstem to key components of the limbic system.
EYFP is strongly expressed throughout the dendritic and axonal arbours of YFP-PPG neurons in the brainstem. Varicose axonal projections can be observed throughout the bed
nucleus of the stria terminalis (BNST; dorsal and ventral to the anterior commissure (ac)) (A), the medial (MS) and lateral septum (LS; B), the diagonal band of Broca (DB) but not the
nucleus accumbens core (NAcC) or shell (NAcS; C), the central subnucleus of the aymgdala (CeA; D) and throughout the ventral tegmental area (VTA; E). The distribution of ﬁbres
throughout the mesolimbic system can be seen in the line diagrams (F), of particular note are the clustering of ﬁbres around all rostro-caudal aspects of the BNST. All scale bars equal
200 mm. 3 V: third ventricle; LV: lateral ventricle; MM: medial mammillary nucleus; opt: optic tract; SHi: septohippocampal nucleus; VP: ventral pallidum.
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were regular ﬁring cells without the pronounced inward rectiﬁca-
tion of type III cells (Daniel et al., 2017; Rodriguez-Sierra et al.,
2013). The neurons recorded here concurred with these published
observations, however type II was themost abundant type amongst
the GLP-1R neurons analyzed here. Altogether, 89 cells were clas-
siﬁed; of these 34 were type 1, 41 type II and 14 type III (Fig. 6C).
Upon establishing the whole-cell conﬁguration, cells were
recorded in current clamp for a minimum of 5 min without any
manipulation. Only cells that maintained a stable membrane po-
tential over this period of time were further characterized. These
cells exhibited a resting membrane potential of 60.2 ± 1.4 mV
(n ¼ 35) and an input resistance of 426 ± 44 MOhm. All recorded
red ﬂuorescent cells responded to bath application of 100 nM GLP-
1, which caused a depolarization of 3.9 ± 0.5 mV (p < 0.001) in 11 of
28 cells tested and a hyperpolarization of 4.6 ± 1.0mV (p< 0.001) in
the remaining 17 (Fig. 6D). Both the depolarizing (4.3 ± 0.7 mV,n ¼ 3, p < 0.05) and hyperpolarizing (4.2 ± 1.3 mV, n ¼ 4, p < 0.01)
responses persisted in the presence of 0.5 mMTTX,10 mMDNQX and
25 mM APV, suggesting that they are due to direct postsynaptic
effect of GLP-1 on the recorded cells.
In order to characterize the biophysical changes associated with
the GLP-1 responses in more detail, voltage clamp recordings were
performed. Cells were held at 50 mV and 100 nM GLP-1 was
applied. Seven of the 13 cells recorded exhibited an outward cur-
rent of 8 ± 4 pA (p < 0.05; Fig. 6E), whilst the remaining 6 cells
exhibited an inward current of 6 ± 3 pA, which did not reach sig-
niﬁcance (p ¼ 0.47). In three cells it was conﬁrmed that the out-
ward current at 50 mV was associated with an increase in
conductance with a reversal potential close to 80 mV, indicative
of the opening of a Kþ channel (Fig. 6F).
The BNST receives dopaminergic input from the VTA and the
PAG acting on reward and stress pathways (Daniel and Rainnie,
2016; Kash, 2012). We next examined whether GLP-1R expressing
Fig. 2. Virally mediated cre-dependent tracing of NTS PPG projections reveals strongly targeting of the BNST.
Bilateral stereotaxic injections of AAV encoding a Cre-dependent Channel Rhodopsin 2 EYFP fusion protein were targeted to the NTS (A). Projections from the NTS PPG neurons
could be observed within known target areas including the dorsomedial hypothalamus (DMH; B) and paraventricular nucleus (PVN; C). Strong axonal projections with varicose
terminal sprays could be observed within the BNST dorsal and ventral to the anterior commissure (ac; D) All scale bars equal 200 mm. 3 V: third ventricle; Arc: arcuate nucleus; LV:
lateral ventricle; MnPO: median preoptic nucleus; MPA: medial preoptic area; MS: medial septum; VMN: ventromedial nucleus of the hypothalamus.
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whether the dopamine response diverges between cells respond-
ing to GLP-1 differently (Fig. 7). In cells which had previously
depolarized in response to GLP-1 we observed a hyperpolarization
of 5.1 ± 1.7 mV (n ¼ 5, p ¼ 0.02). In cells which had previously
hyperpolarized to GLP-1 we observed a depolarization of
13.2 ± 4.0 mV (n ¼ 3, p < 0.05).3.4. Projections from GLP-1R neurons in the BNST
Here we conﬁrm our previous reports of a high density of GLP-1R cells in the BNST (Cork et al., 2015) (Fig. 8A & C). The projection
targets of these cells were determined with a Cre-dependent AAV
encoding ChR2:EYFP (Fig. 8DeG). Injection of 200 nl of AAV-
ChR2:EYFP into the BNST of GLP-1R-CRE:tdRFP mice at
Bregma þ0.25 mm led to EYFP expression in tdRFPþ cell bodies
from Bregma þ0.50 mm to 0.60 mm, conﬁrming that only cells
expressing cre-recombinase enabled EYFP expression (Fig. 8C).
EYFPþ cell bodies were found primarily in the BNST subnuclei, but
also some in the medial septum (MS) and the ventral part of the LS
(Fig. 8C, D). At Bregma 0.60 mm EYFPþ cell bodies were observed
in the BNST nuclei around the fornix as well as the neighboring
Fig. 3. GLP-1R stimulation in the BNST suppresses food intake. (A) Chow intake after
intra-BNST injection of GLP-1 is reduced in the ﬁrst 4 h of the dark phase. (B) Intra-
BNST injection of the GLP-1R antagonist Ex9 increases chow intake during the ﬁrst
4 h of the dark phase. (C) In mice maintained on HFD, intra-BNST injection of GLP-1
suppresses feeding, but only up to 2 h after dark onset, and only at the higher
doses. (D) HFD maintenance eliminates the feeding response to intra-BNST Ex9. (E, F)
Representative images of a coronal sections from 2 different subjects showing BNST
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hypothalamus. All areas with EYFPþ cell bodies also exhibited a
dense network of dendrites and non-varicose axons.
Varicose axons extended up to approximately 2.00 mm anterior
from Bregma. No varicose axons were observed dorsal to the rhinal
ﬁssure, few were seen in the piriform cortex, and moderate
numbers were found along the midline. More caudally, varicose
axons along the midline persisted, being found in the infralimbic
cortex and prelimbic cortex, as well as in the NAcC with increased
density in its ventral part. Few axons were seen close to the ventral
surface, and occasional axons in the piriform cortex. Innervation
density increased at Bregma þ1.40 mm, with dense innervation of
both the dorsal and intermediate LS (Fig. 8E) as well as the NAcS.
Moderate innervation occurred along the midline both dorsal and
ventral from these nuclei, and few GFP-IR axons were found in the
piriform cortex, as well as in the NAcC. More caudally (Bregma
1.10 mme0.86 mm), piriform innervation was lost, but innervation
of LS and NAcS increased. In contrast, therewere few varicose axons
in themedial septal nucleus and the NAcC. No axons were observed
lateral from the ventricles or dorsal to the corpus callosum. Dense
innervation with varicose axons was observed in the OVLT and the
median preoptic nucleus with moderate innervation of the lateral
part of the preoptic area.
Caudal from the BNST, at Bregma 0.60 mm, the subfornical
organ and the anterodorsal thalamic nucleus were densely inner-
vated. Fromhere onwards amoderate density of varicose axonswas
seen in the paraventricular thalamic nucleus with few axons
running down to the PVN which exhibited a high density of vari-
cose axons (Fig. 8F). Similarly, many varicose axons were found in
the nuclei of the central amygdala, but virtually no axons in the
basolateral amygdala and piriform cortex (Fig. 8F).
No innervation was observed in the rostral hippocampus or the
cortex, but there was moderate density of varicose axons in the
thalamus just below the dorsal third ventricle, running towards the
third ventricle, where they fanned out laterally. Dense innervation
was found in the dorsomedial hypothalamus except the area
directly adjacent to the third ventricle (Fig. 8G). A moderate density
of varicose axons was seen throughout the hypothalamus, with
notably less innervation of ARC and median eminence (Fig. 8G). At
the level of the aqueduct many varicose axons were observed in the
periaqueductal gray, from there moderate numbers of axons proj-
ect ventrally along the midline and spread from the fasciculus
retroﬂexus towards the medial lemniscus. Some axons were found
in the rostral VTA and dense innervation occurred around the
dorsal border of the retromammillary nucleus, with the nucleus
itself and the other mammillary nuclei devoid of innervation. At
Bregma 3.5 mm, dense innervation with varicose axons was seen
in the interfascular nucleus, the parainterfascular nucleus and the
paranigral nucleus of the VTA, but not in the interpendicular nu-
cleus. Similarly, more lateral axons extended up to the medial
lemniscus, but not to the substantia nigra, which was devoid of
projections. Moderate numbers of varicose axons were observed
along the midline up to the aqueduct and in the mesencephalic
reticular formation. Innervation was dense in the lateral, and
moderate in the dorsomedial, periaqueductal gray. Moderate
numbers of varicose axons were observed in the amygdalohippo-
campal area. Sections more caudal than the aqueduct were not
systematically analyzed. Projections to the NTS were present, but
sparse.injection sites. Panel E shows an injection that was entirely within the dorsal BNST, and
F shows an injection that extended into the ventral BNST. Inj. ¼ injection damage. Data
are means ± SEM, *p < 0.05 in Holm-Bonferroni comparison with vehicle conditions at
their respective timepoints.
Fig. 4. GLP-1R antagonist injected into the NAc has no effect on feeding. (A) Chow intake after intra-NAc injection of Ex9. (B) Representative image of a coronal section showing an
NAc injection site. ICjM ¼ Island of Calleja, Major island.
Fig. 5. Acute restraint stress suppresses subsequent chow intake at 4 h after dark
onset, and pretreatment with intra-BNST Ex9 attenuates this anorexic effect of stress.
Data are means ± SEM, *p < 0.05 in Holm-Bonferroni comparisons with all other
conditions at the 4 h timepoint.
D.L. Williams et al. / Neuropharmacology 131 (2018) 83e95904. Discussion
Our data show that injection of exogenous GLP-1 directly into
the BNST potently reduces food intake in mouse, suggesting the
BNST is a potential target for the weight-reduction effects of GLP-1
analogues. We also establish that blocking GLP-1 receptors in the
BNST by microinjection of the GLP-1R antagonist Ex9 signiﬁcantly
increases acute food intake, verifying BNST GLP-1Rs as physiolog-
ically relevant target for endogenous GLP-1. This is further sup-
ported by our data showing that NTS PPG neurons, which
constitute the most likely source of GLP-1 within the CNS, project
strongly to the BNST. Furthermore, we found that GLP-1 elicits both
excitatory and inhibitory electrical responses at cellular level
within the BNST. This suggests that food intake effects of GLP-1
within the BNST are obtained through action on both orexigenic
and anorexigenic pathways. Finally, the projection pattern of GLP-
1R expressing cells in the BNST was established, in order to gain
some insight into the downstream signaling pathways.
4.1. Exogenous and endogenous GLP-1 in the BNST affects food
intake
Our data support a role for BNST GLP-1R in the physiological
control of food intake, and suggest that this site may contribute to
the feeding-suppressive effects of peripheral long-acting GLP-1R
agonist treatments. Blockade of BNST GLP-1R increased feeding innon-stressed mice maintained on chow diet, suggesting that tonic
endogenous activation of these receptors functions to limit feeding
under normal conditions. We also examined the potential contri-
bution of GLP-1R in the NAc, which has been previously identiﬁed
as a region at which GLP-1R stimulation suppresses feeding in the
rat (Alhadeff et al., 2012; Dossat et al., 2011). In the mouse, we
found that delivery of the same doses of Ex9 that increased intake
when delivered to the BNST failed to affect chow intake when
injected into the NAc. This is consistent with the relatively sparse
PPG innervation of the NAc observed here, and suggests that brain
areas such as the BNST and others that receive a higher density of
PPG input may be more important for the control of feeding in the
mouse.
In addition, BNST GLP-1R blockade attenuated stress-induced
hypophagia in the mouse. This is consistent with ﬁndings in the
rat suggesting that GLP-1 input to the BNST may be activated by
acute stress (Maniscalco et al., 2015). It is worth noting that in this
experiment, we did not obtain a signiﬁcant increase in chow intake
after intra-BNST injection of Ex9 in the no-stress condition. We
suggest that this is due to design differences between our stress
experiment and the dose response experiment. In the restraint
stress experiment, the vehicle vs Ex9 comparison is between-
subjects, with both groups of a lower n than the entirely within-
subjects dose response experiment, and more variability in intake
across subjects. Therefore, we have lower power to detect a dif-
ference between those two conditions in the stress study, despite
the trend toward increased intake with Ex9. However, the focus of
this experiment is on the hypophagic effect of stress, and we see in
these data that mice that received BNST Ex9 did not exhibit the
restraint-induced anorexia that is observed in the vehicle-injected
control group. Interestingly, PVN knockdown of GLP-1R revealed
that these receptors are critical for a number of physiological re-
sponses to stress, though stress-induced hypophagia was not
measured in that paper (Ghosal et al., 2017). Together these data
highlight the diversity of the neural circuitry involved in the brain's
response to stress. Based on our results, we conclude that endog-
enous GLP-1 action in the BNST is involved in homeostatic feeding
control under non-stressed conditions, as well as in the anorexic
response to acute stress.
When mice were maintained on HFD, the effects of BNST GLP-1
and Ex9 treatment were not as robust as on chow-fed mice. The
duration of the GLP-1 effect was shorter, and higher doses were
required to elicit measureable effects. Blockade of BNST GLP-1R
failed to inﬂuence feeding at all in the HFD-maintained mice.
Given the effects of pharmacological GLP-1R stimulation here, we
can conclude that HFD does not eliminate GLP-1R expression or
Fig. 6. GLP1R expressing neurons display either excitatory or inhibitory responses to GLP-1.
(A) Recordings made in the cell-attached conﬁguration showed that GLP-1 causes either an increase or decrease in ﬁring frequency of BNST GLP-1R neurons. (B) Mean ﬁring rate of
GLP-1 excited (left) and GLP-1 inhibited (right) BNST neurons before, during and after 100 nM GLP-1. (C) GLP-1R neurons fall into three groups. Type I (left) is characterized by
sustained ﬁring and little inward rectiﬁcation. Type II (middle) is characterized by rebound spikes and h-type currents (arrows). Type 3 (right) is characterized by inward recti-
ﬁcation (arrow). (D) Representative current clamp recording shows that in a neuron visually conﬁrmed to express GLP-1R bath application of GLP-1 evoked a hyperpolarization
leading to cessation of action potential ﬁring. The response reverses after washout of GLP-1. The overlaid traces on the right demonstrate that the hyperpolarization under GLP-1
(red trace) is accompanied by an increase in membrane conductance. (E) The cell displayed in D recorded in voltage clamp at a holding potential of 50 mV. Bath-application of
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Fig. 7. GLP-1R expressing BNST neurons respond to GLP-1 and dopamine in a reciprocal fashion.
Representative current clamp recordings show that in neurons visually conﬁrmed to express GLP-1R bath application of GLP-1 evoked either a small depolarization (A) or a small
hyperpolarization (B). Cells that depolarized under GLP-1 exhibited a small hyperpolarization upon bath application of dopamine (bottom panel in A). Other neurons responded to
bath application of GLP-1 by hyperpolarizing, and these cells depolarized under dopamine (B). Mean data for these two cell types is shown in C and D, respectively.
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endogenous GLP-1 release in the BNSTmay be reduced by HFD, and
the reduced effectiveness of GLP-1 itself raises the possibility that
BNST GLP-1R have reduced sensitivity or signaling capacity under
these conditions. It is possible that HFD decreases, but does not
eliminate, GLP-1R expression or availability in BNST cells, or that
HFD reduces GLP-1's binding afﬁnity or efﬁcacy at the receptor.
Whatever the mechanism, the impaired response to GLP-1 in the
BNST under HFD conditions may contribute to the over-
consumption and weight gain observed.4.2. PPG neuron projections to the BNST
The most likely source of the endogenous GLP-1 reaching the
BNST is the PPG neurons of the lower brainstem. Indeed, visual-
isation of YFP immunoreactivity in the mesolimbic system in YFP-
PPG mice demonstrated substantial innervation of the BNST with
varicose PPG axons. This is consistent with previous reports of GLP-
1R mRNA expression (Merchenthaler et al., 1999), BNST GLP-1
speciﬁc immunoreactivity in rat (Gu et al., 2013), GLP-1R pro-
moter activity in mouse (Cork et al., 2015) and BNST speciﬁc, ICV
delivered, GLP-1-dependant activation of c-fos (Gu et al., 2013;
Rowland et al., 1997). In contrast, innervation of the NAc shell
was low, and very few PPG axons were actually seen within the
nucleus itself. Similarly, few PPG axons were seen in the LS. Larger
numbers of axons were observed in the VTA. Previous studies in rat
have demonstrated intake-suppressive effects of endogenous GLP-
1 in the NAc and VTA (Alhadeff et al., 2012; Dossat et al., 2011),100 nM GLP-1 elicits an outward current that reverses upon washout of GLP-1. Downward d
respectively. Individual responses to these injections are shows on the right, with control
current at 90 mV. Arrows in D and E indicate A-current. (F). Current-voltage relationship
to 90 mV, 70 mV, 50 mV and 30 mV under control (black) and in GLP-1 (red). (For int
Web version of this article.)indicating that modest innervation might be physiologically rele-
vant. This would suggest that the BNST innervation observed here
is of signiﬁcant importance.
Whilst it might be a reasonable assumption that the innervation
of the BNST stems from the PPG neuron cell bodies located in the
NTS of the lower brainstem, we veriﬁed this by targeting the NTS of
mGlu-Cre:tdRFP mice with cre-dependent AAVs encoding ChR2-
eGFP. These experiments revealed a virtually identical pattern of
GFP-IR axons in the BNST to that observedwith the YFP-PPGmouse,
thus demonstrating that these axons indeed originate from the PPG
neurons in the NTS. It remains to be determined functionally in
future experiments that these PPG axons release the GLP-1 acting
on the BNST neurons, though we consider this most likely.4.3. Electrophysiological responses
GLP-1R-expressing cells in the BNST were located both dorsal
and ventral from the anterior commissure and their electrophysi-
ological ﬁngerprint was rather variable, with individual GLP-1R
cells corresponding to the previously deﬁned electrophysiological
cell types I to III. Whilst type II cells make up the largest fraction of
GLP-1R cells, type I and III also contributed, with types I and II more
abundant than reported for molecularly undeﬁned BNST neurons in
mouse, but similar to the distribution observed in rat (Daniel et al.,
2017; Rodriguez-Sierra et al., 2013). Cellular effects of GLP-1 within
the BNSTwere both excitatory and inhibitory. However, this neither
correlated with the electrophysiological cell type, nor with the
dorsal or ventral location of the individual cell within the BNST.eﬂections in left hand traces in D and E indicate 500 ms current and voltage injections,
traces in black and GLP-1 traces in red. Note outward current at 50 mV, but lack of
(IV) for a hyperpolarizing cell. The inset shows the current response to voltage steps
erpretation of the references to colour in this ﬁgure legend, the reader is referred to the
Fig. 8. Virally-mediated cre-dependent tracing of BNST GLP1-R expressing neurons shows projections to target feeding circuits.
tdRFP expression in GLP1-R cre mice reveal the presence of GLP1-R-expressing neurons within the BNST, dorsal and ventral to the anterior commissure (A). Cre expression in these
neurons enabled GLP-1R-speciﬁc tracing by bilateral injections of AAV, dorsal and ventral to the anterior commissure (ac; B). Clear co-localisation of ChR2 eYFP and GLP-1R RFP
expression was observed within the BNST, see inset for cytoplasmic RFP expression (red) and membrane-bound ChR2 eYFP (green) (C). ChR2 eYFP expression was strong within the
BNST and could be seen coursing through the fornix (D). Within the dorsal lateral septum (dLS) ChR2:EYFP positive axons could be observed along the border of the lateral ventricle
(LV) in close association with neurons expressing GLP-1R (E). Moving further from the BNST, EYFP containing axons could be observed within the paraventricular nucleus (PVN), the
amygdaloid complex (F), and also the ventromedial hypothalamus (VMN; G). All scale bars equal 200 mm. 3 V: third ventricle; Arc: arcuate nucleus; CeA: central amygdaloid
nucleus; LV: lateral ventricle; ME: median eminence; MeA: medial amygdaloid nucleus; MPA: medial preoptic area; MS: medial septum; Pir: piriform cortex. (For interpretation of
the references to colour in this ﬁgure legend the reader is referred to the Web version of this article.)
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et al., 2016) it could be seen as surprising that inhibitory elec-
trical responses were observed. However, at least in recombinant
systems, GLP-1R has been demonstrated to be capable of signaling
through Gq and Gi (Montrose-Raﬁzadeh et al., 1999). Additionally, arecent study investigating electrophysiological responses to GLP-1
in the paraventricular thalamic nucleus (PVT) reported inhibitory
responses to GLP-1 that were partially cell autonomous and
partially presynaptic (Ong et al., 2017). Furthermore, we have
previously observed in hippocampus that GLP-1R neurons exhibit
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that the inhibitory hyperpolarizing response was caused by the
activation of a Kþ current (Cork et al., 2015). This latter observation
was conﬁrmed for some of the hyperpolarizing BNST neurons in the
present study, although, like in Ong et al. (2017), in a number of
cells the amplitude of the responsewas too small to allow deﬁnitive
detection of a Kþ current mediated effect. Independent of the ionic
identity of the GLP-1 evoked current, our ﬁndings and those of Ong
and colleagues might indicate that in neurons, coupling to Gs is not
obligatory for GLP-1R.
The observation that similar proportions of BNST cells respon-
ded with excitation and inhibition in both cell-attached as well as
whole-cell recordings increases the conﬁdence that this is a phys-
iologically relevant response. Given that the physiological outcome
of GLP-1 application within the BNST was always anorectic, it
would suggest that GLP-1 can act on both orexigenic and anorexi-
genic circuitry, inhibiting the former and activating the latter. The
observation that cells inhibited by GLP-1 were activated by dopa-
mine, and cells activated by GLP-1 were inhibited by dopamine
further supports the hypothesis that GLP-1 acts differentially on
two opposing cellular circuits within the BNST. Furthermore, the
fact that within the BNST, GLP-1 and dopamine act on the same
cells, suggests that orexigenic and anorexigenic pathways merge at
this level. GLP-1 is clearly deﬁned as a satiety peptide whilst
enhanced striatal dopamine release has been linked to the activa-
tion of a hedonic orexigenic ‘appetition’ pathway (Han et al., 2016;
Shechter and Schwartz, 2016). In that respect our ﬁnding that the
electrical responses to dopamine and GLP-1 were the opposite in
individual cells seems rather appropriate.
Whilst it is unclear whether the dopamine pathway thought to
be involved in hedonic food seeking extends to the BNST, it is well
established that the BNST receives strong dopaminergic input
(Freedman and Cassell, 1994). Electrophysiological analysis found
that only a small proportion of unidentiﬁed BNST neurons exhibi-
ted postsynaptic effects upon dopamine application (Kash et al.,
2008). A second electrophysiological study selectively recording
from corticotropin-releasing factor (CRF) neurons revealed that
these neurons are depolarized by dopamine (Silberman et al.,
2013). It is unclear whether the depolarizing subgroup of GLP-1R
cells recorded in our study corresponds to these CRF neurons. No
previous electrophysiological study has reported a hyperpolarizing
response to dopamine in the BNST.
The BNST has been implicated in the integration of stress and
reward behavior, as well as in both anxiogenic and anxiolytic effects
and both inhibition and stimulation of food intake (Betley et al.,
2013; Kash et al., 2015). Given this dichotomy in various aspects
of behavior, it might not be surprising to observe these two
opposite electrical effects to GLP-1 as well as dopamine.
4.4. BNST projections
The BNST has extensive connectivity with the brainstem, hy-
pothalamic and limbic structures, and is recognized for its corre-
sponding role in autonomic, neuroendocrine and behavioral
functions (Crestani et al., 2013). Most notably, it is known for pro-
cessing reward/addiction and stress/anxiety, but has recently been
shown to have an additional role in appetitive responses. This
model of BNST circuitry suggests it to be an important site of he-
donic and homeostatic signal integration. Arguably the most
comprehensive analysis of BNST projections has been performed in
rat (Dong and Swanson, 2004a, b). These studies analyzed pro-
jections from the various BNST subnuclei, but not of speciﬁc cell-
types within the BNST. In contrast, our study only labeled
projections from those BNST neurons that express GLP-1R. Com-
parison of the projection pattern obtained by us with that from ratrevealed a largely overlapping pattern and suggests that the BNST
GLP-1R neurons are a subpopulation of BNST cells that is repre-
sentative for the entire population, rather than a subgroup that only
projects to few select targets. Consequently, it might be expected
that GLP-1 can inﬂuence the majority, if not all, of the physiological
functions assigned to BNST neurons. This conclusion is made,
however, under the presumption that rat and mouse projection
patterns of BNST neurons do not differ signiﬁcantly.
Electrophysiology and tracing studies have shown it receives
glutamatergic inputs from the hippocampus and medial prefrontal
cortex, and in turn projects to dopamine neurons in the VTA
(Jalabert et al., 2009). The BNST is also thought to send GABAergic
inhibitory projections to the lateral hypothalamus (LH), which
suppresses LH glutamatergic neurons to promote feeding. Opto-
genetic activation of this pathway induced voracious feeding,
reinforced motivational behaviours for subsequent light stimula-
tion, and increased preference for high-fat food (Jennings et al.,
2013). Conversely, photoinhibition suppressed feeding in starved
mice, and triggered avoidance behaviour (Jennings et al., 2013).
We found that BNST GLP-1R-expressing cells project to many
established BNST target sites that have known roles in the control
of energy balance and stress responses, including among others the
LS, PVN, dorsomedial hypothalamus, and CeA. Notably, we
observed a high density of BNST GLP-1R cell ﬁbers in regions that
are themselves known to express GLP-1R, and in some cases are
established locations for GLP-1R action on behavior and physiology.
For example, the PVN displayed heavy innervation in this study,
and GLP-1R in the PVN have recently been shown to play a medi-
atory role in several aspects of the stress response (Ghosal et al.,
2017). As can be seen in Fig. 8E, the LS receives projections from
these BNST GLP-1R cells, and many cells within the LS also express
GLP-1R. The dorsal LS, in particular, is a site where endogenous
GLP-1 action suppresses food intake and motivation for palatable
food in the rat (Terrill et al., 2016). The VTA is another such
example, receiving input from the BNST GLP-1R neurons in our
study, and established as a site of action for GLP-1's suppressive
effects on feeding and cocaine self-administration in the rat
(Alhadeff et al., 2012; Schmidt et al., 2016). Many of these brain
regions, in turn, project reciprocally to the BNST, though we do not
knowwhether those projections include axons fromGLP-1R cells in
those locations.
Collectively, these results indicate the vital role of afferent
projections to, and efferent projections from the BNST in a critical
feeding circuitry, and our results suggest that GLP-1 plays a sig-
niﬁcant part in this circuit.
5. Conclusions
This study reveals further complexity in the central GLP-1 cir-
cuitry than previously assumed, with interconnections among the
brain regions and cells that receive endogenous GLP-1 input from
the hindbrain PPG neurons as well as a mixture of excitatory and
inhibitory responses at cellular level. Such an arrangement could
function to coordinate a neuroanatomically diverse network to
execute multi-faceted behavioral and physiological responses, such
as feeding, stress and anxiety, motivation and reward seeking
behaviors.
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